The Valley Desk

NCT03559270 · Interventional trial

A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

Overall registry status Terminated

Phase 3

Conditions Atopic Dermatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov